S. Gelderbloem

发表

Running Title: AERAS-402 induces robust T cell immunity in adults

M. Tameris, J. McClain, G. Hussey, 2010 .

The novel tuberculosis vaccine, AERAS-402, induces robust and polyfunctional CD4+ and CD8+ T cells in adults.

M. Tameris, M. Hatherill, J. McClain, 2010, American journal of respiratory and critical care medicine.

Specific T cell Frequency and Cytokine Expression Profile Do Not Correlate with Protection against Tuberculosis, Following BCG Vaccination of Newborns

G. Kaplan, M. Hatherill, T. Scriba, 2010 .

Novel application of a whole blood intracellular cytokine detection assay to quantitate specific T-cell frequency in field studies.

P. Haslett, G. Kaplan, G. Hussey, 2004, Journal of immunological methods.

A phase IIa trial of the new tuberculosis vaccine, MVA85A, in HIV- and/or Mycobacterium tuberculosis-infected adults.

M. Tameris, M. Hatherill, T. Scriba, 2012, American journal of respiratory and critical care medicine.

Dose-Dependent Immune Response to Mycobacterium bovis BCG Vaccination in Neonates

G. Kaplan, G. Hussey, W. Hanekom, 2006, Clinical and Vaccine Immunology.

HIV-1 infection in infants severely impairs the immune response induced by Bacille Calmette-Guérin vaccine.

G. Kaplan, M. Tameris, T. Scriba, 2009, Journal of Infectious Diseases.

Feasibility of establishing a biosafety level 3 tuberculosis culture laboratory of acceptable quality standards in a resource-limited setting: an experience from Uganda

P. Musoke, M. Joloba, H. Mayanja-Kizza, 2015, Health Research Policy and Systems.

Significantly skewed memory CD8+ T cell subsets in HIV-1 infected infants during the first year of life.

G. Kaplan, M. Tameris, T. Scriba, 2009, Clinical immunology.

Bacillus Calmette-Guérin Vaccination of Human Newborns Induces T Cells with Complex Cytokine and Phenotypic Profiles1

G. Kaplan, H. Maecker, T. Scriba, 2008, The Journal of Immunology.

Complex Cytokine and Phenotypic Profiles Human Newborns Induces T Cells with Bacillus Calmette-Guérin Vaccination of

G. Kaplan, H. Maecker, T. Scriba, 2008 .

Development of a TB vaccine trial site in Africa and lessons from the Ebola experience

K. Laserson, J. Richardus, G. Blatner, 2020, BMC Public Health.

Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa1

T. Lang, M. Tameris, M. Hatherill, 2012 .

Induction and regulation of T-cell immunity by the novel tuberculosis vaccine M72/AS01 in South African adults.

M. Demoitié, Joe D. Cohen, O. Ofori-Anyinam, 2013, American journal of respiratory and critical care medicine.

Delaying BCG vaccination from birth to 10 weeks of age may result in an enhanced memory CD4 T cell response.

T. Scriba, G. Hussey, W. Hanekom, 2009, Vaccine.

Distinct, Specific IL-17- and IL-22-Producing CD4+ T Cell Subsets Contribute to the Human Anti-Mycobacterial Immune Response1

R. Wilkinson, T. Scriba, G. Hussey, 2008, The Journal of Immunology.

Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette-Guérin vaccination of newborns.

G. Kaplan, M. Hatherill, T. Scriba, 2010, American journal of respiratory and critical care medicine.

The effect of bacille Calmette-Guérin vaccine strain and route of administration on induced immune responses in vaccinated infants.

G. Kaplan, G. Hussey, W. Hanekom, 2006, The Journal of infectious diseases.

T cell receptor repertoires associated with control and disease progression following Mycobacterium tuberculosis infection

G. Schoolnik, F. Miedema, D. Tabb, 2023, Nature Medicine.

Modified vaccinia Ankara‐expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cells

M. Tameris, M. Hatherill, T. Scriba, 2009, European journal of immunology.

Dose-finding study of the novel tuberculosis vaccine, MVA85A, in healthy BCG-vaccinated infants.

M. Tameris, M. Hatherill, T. Scriba, 2011, The Journal of infectious diseases.

Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa.

T. Lang, M. Tameris, M. Hatherill, 2008, The Journal of infectious diseases.

Tuberculin skin test and QuantiFERON® assay in young children investigated for tuberculosis in South Africa.

M. Pai, M. Tameris, M. Hatherill, 2011, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response

Daniel E. Zak, D. Zak, G. Schoolnik, 2020, Scientific Reports.

Qualification of a whole blood intracellular cytokine staining assay to measure mycobacteria-specific CD4 and CD8 T cell immunity by flow cytometry.

G. Kaplan, T. Scriba, G. Hussey, 2015, Journal of immunological methods.

Multidimensional analyses reveal modulation of adaptive and innate immune subsets by tuberculosis vaccines

S. Omarjee, Greg Finak, S. Gurunathan, 2020, Communications Biology.

ResponseHuman Anti-Mycobacterial Immune T Cell Subsets Contribute to the + CD4Distinct, Specific IL-17- and IL-22-Producing

R. Wilkinson, T. Scriba, G. Hussey, 2008 .

Modified vaccinia Ankara‐expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cells

M. Tameris, M. Hatherill, T. Scriba, 2009, European journal of immunology.

Dose-finding study of the novel tuberculosis vaccine, MVA85A, in healthy BCG-vaccinated infants.

M. Tameris, M. Hatherill, T. Scriba, 2011, The Journal of infectious diseases.

HIV-1 infection in infants severely impairs the immune response induced by Bacille Calmette-Guérin vaccine.

G. Kaplan, M. Tameris, T. Scriba, 2009, The Journal of infectious diseases.